---
figid: PMC7988715__ol-21-05-12637-g01
figtitle: EZH2 overexpression in prostate cancer
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC7988715
filename: ol-21-05-12637-g01.jpg
figlink: pmc/articles/PMC7988715/figure/f2-ol-0-0-12637/
number: F2
caption: 'EZH2 overexpression in prostate cancer. The following steps are involved:
  1. ERG-dependent mechanisms. Upregulation of the PI3K/Akt signaling pathway by PTEN
  mutations increases AR signaling and contributes to ERG overexpression in ETS(+)
  tumors. TMPRSS2-ERG fusion leads to overexpression of ERG, leading to overexpression
  of the EZH2 protein. 2. MYC oncogene binds to the E-box of the EZH2 promoter and
  induces its expression. 3. Post-transcriptional regulation of EZH2 by miRNAs. miR101,
  miR26a and miR26b reduces the translation of EZH2. Genomic loss of miR-101 and overexpression
  of MYC, which represses the transcription of miR-26a and miR-26b, increases EZH2
  translation. 4. EZH2 is involved in gene silencing of TSG, NKX3-1. miR, microRNA;
  TSG, tumor suppressor gene; EZH2, enhancer of zeste 2 polycomb repressive complex
  2 subunit; ERG, ETS transcription factor ERG; AR, androgen receptor; TMPRSS2, transmembrane
  serine protease 2; EBS, ETS binding site; NKX3-1, NK3 homeobox 1; ARE, androgen
  response elements.'
papertitle: Decoding the heterogeneous landscape in the development prostate cancer.
reftext: Yenifer Yamile Segura-Moreno, et al. Oncol Lett. 2021 May;21(5):376.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9141117
figid_alias: PMC7988715__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC7988715__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7988715__ol-21-05-12637-g01.html
  '@type': Dataset
  description: 'EZH2 overexpression in prostate cancer. The following steps are involved:
    1. ERG-dependent mechanisms. Upregulation of the PI3K/Akt signaling pathway by
    PTEN mutations increases AR signaling and contributes to ERG overexpression in
    ETS(+) tumors. TMPRSS2-ERG fusion leads to overexpression of ERG, leading to overexpression
    of the EZH2 protein. 2. MYC oncogene binds to the E-box of the EZH2 promoter and
    induces its expression. 3. Post-transcriptional regulation of EZH2 by miRNAs.
    miR101, miR26a and miR26b reduces the translation of EZH2. Genomic loss of miR-101
    and overexpression of MYC, which represses the transcription of miR-26a and miR-26b,
    increases EZH2 translation. 4. EZH2 is involved in gene silencing of TSG, NKX3-1.
    miR, microRNA; TSG, tumor suppressor gene; EZH2, enhancer of zeste 2 polycomb
    repressive complex 2 subunit; ERG, ETS transcription factor ERG; AR, androgen
    receptor; TMPRSS2, transmembrane serine protease 2; EBS, ETS binding site; NKX3-1,
    NK3 homeobox 1; ARE, androgen response elements.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ar
  - Erg
  - Tmprss2
  - Alpha-re
  - Ezh2
  - Myc
  - Nol3
  - Mir101a
  - Mir26a-1
  - Mir26b
  - Nkx3-1
  - AR
  - ERG
  - TMPRSS2
  - EZH2
  - MYC
  - MIR26A1
  - MIR26B
  - NKX3-1
---
